Levulinic acid as a new platform for green chemistry: The Digest’s Multi-Slide Guide to GF Biochemicals

In February, GFBiochemicals announced at ABLC 2016 that it has acquired the assets and intellectual property of Segetis, a US-based, venture-backed levulinic acid derivatives producer Segetis has more than 50 patents and over 200 pending patent applications worldwide.

The acquisition matches up GF Biochemical’s commercial-scale technology for producing levulinic acid, with Segetis’ technology for converting levulinic acid into biobased intermediates and speciality chemicals in plasticizers, fragrances, household and industrial cleaners, biobased acrylate polymers, agrochemical formulations, polyester and polyurethane intermediates, polycarbonate co-monomers, and nylon intermediates.

Marcel van Berkel, Chief Commercial Officer of GFBiochemicals, gave this presentation in February of the opportunities for the combined companies.